Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Health Choice Advocates, LLC v. Gilead Sciences, Inc. et al
Case Number:
5:17-cv-00121
Court:
Nature of Suit:
Judge:
Firms
- Carter Arnett
- Howry Breen
- Husch Blackwell
- Jones Day
- Lanier Law Firm
- McDermott Will & Emery
- McKool Smith
- Noroozi PC
- Patton Tidwell
- Quinn Emanuel
- Reese Marketos
- Ropes & Gray
- Siebman Law
Companies
Sectors & Industries:
-
April 17, 2019
DOJ Dismissal Power Looking Wobbly In FCA Cases
The U.S. Department of Justice's newly launched campaign to shrink its False Claims Act docket has hit surprising turbulence as federal judges scrutinize the DOJ's willingness to look the other way on alleged fraud and its disparagement of a company that specializes in bringing FCA cases.
-
January 23, 2019
FCA Co. Torches DOJ Effort To Scuttle Suits
A company that specializes in bringing False Claims Act cases has launched a scorched-earth attack on the U.S. Department of Justice for seeking dismissal of nearly a dozen suits it filed, accusing the DOJ of trying to "legalize certain kickbacks" to doctors from drugmakers.
-
December 18, 2018
DOJ Aims Torpedo At 11 FCA Kickback Suits
In a striking development, the U.S. Department of Justice is seeking to terminate 11 False Claims Act cases involving a new theory that patient assistance services supplied by drugmakers are unlawful kickbacks.